Search

everythinglearnresearchcommunity

for

Search:↓

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

JAK inhibitors offer new hope for treating severe alopecia areata.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Ch55 may help reduce skin scarring and fibrosis.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Tofacitinib taken by mouth helps treat hair loss in children.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib, a hair regrowth treatment, may worsen acne.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.